medi-cal no longer covering glp-1 As of January 2026, important changes to can affect eligibility and coverage for some adults. Here are 4 things you should know: ➡️ Eligibility Changes: Enrollment freeze will affect people in Medi-Cal Rx Members | State
Description
These modifications extend the half-life of the hormone to 2.4 h [18]
These drugs are part of a class of medications known as glucagon-like peptide-1 receptor agonists (GLP-1 receptor agonists or GLP-1 RAs)
Conflating receptor agonism with receptor selectivity
In a cohort of 3731 patients, weight loss of 5%, 10%, and 15% was observed in 63%, 33%, and 14%, respectively, after 56 weeks of treatment (27%, 11%, and 4% with placebo),69 or of an additional 6% at 56 weeks in patients who had already lost 6% through hypocaloric diet and exercise.70 Positive results were also observed in adolescent patients with obesity,71 and in real-life studies substantial weight loss has also been reported.7275 Phase 3 trials with GLP-1 receptor agonists indicated specifically for obesity and overweight
[DOI] [PubMed] [Google Scholar] 31.Cox AR, Lam CJ, Rankin MM, Rios JS, Chavez J, Bonnyman CW, King KB, Wells RA, Anthony D, Tu JX, Kim JJ, Li C, Kushner JA
A reduction in C-reactive protein (CRP) levels was seen across all classes of obesity
